A curated, source-verified library of the strongest available research on harm reduction, treatment outcomes, overdose prevention, and the comparative effectiveness of voluntary versus coercive addictions care. Every entry links to a peer-reviewed journal, government report, university source, or major public-health agency.
Federal, provincial, and municipal public-health reports, coroner data, and official audits.
Showing 24 of 24 entries
Public Health Agency of Canada
Quarterly federal surveillance dashboard of apparent opioid- and stimulant-toxicity deaths, hospitalizations, and EMS responses, broken out by province.
Over 50,000 apparent opioid toxicity deaths in Canada since 2016.
Saskatchewan Coroners Service
Provincial coroner statistics on confirmed and suspected drug-toxicity deaths in Saskatchewan, updated monthly.
Saskatchewan Health Authority
SHA's published inventory of voluntary mental health and addictions services across the province, including detox, residential, and OAT access points.
Health Canada
Federal strategy explicitly grounded in the four pillars: prevention, harm reduction, treatment, and enforcement.
Canadian Centre on Substance Use and Addiction (CCSA)
CCSA / CISUR national costing study, updated periodically. Quantifies the healthcare, criminal-justice, lost-productivity, and other costs of substance use by province.
Substance use cost Canada an estimated $49.1 billion in 2020 (~$1,291/person).
BC Coroners Service
Monthly BC coroner reports — the most detailed sub-national overdose dataset in Canada and a critical comparator for prairie provinces.
Government of Alberta
Public dashboard tracking opioid-related deaths, EMS responses, ED visits, and OAT dispensations across Alberta — useful prairie comparator data.
Government of Manitoba
Provincial reporting on substance-related harms and the public-health response in Manitoba — prairie comparator.
Canadian Institute for Health Information
CIHI's standardized national data on opioid poisoning hospitalizations and emergency department visits, including provincial breakdowns.
Statistics Canada
National household survey data on alcohol, tobacco, cannabis, and illicit-drug use — including by province.
City of Saskatoon
Municipal plans and reporting on community safety, including the response to addictions, homelessness, and harm reduction in Saskatoon.
City of Regina
Regina's municipal plan addressing substance use, mental health, and crisis response.
Office of the Auditor General of British Columbia
Independent provincial audit of the BC government's overdose prevention and prescribed safer-supply implementation, identifying accountability and access gaps.
Health Canada / CRISM
Federally-endorsed clinical practice guideline for OUD treatment, naming buprenorphine and methadone as first-line therapies.
Saskatchewan Coroners Service · Chief Coroner
Official epidemiological dataset of confirmed and suspected fatal drug poisonings across Saskatchewan, Jan 2021 – Apr 2026.
331 suspected/confirmed deaths in 2025 (down from a peak of 455 in 2023); supply driven by parafluorofentanyl, methylfentanyl, benzodiazepines and xylazine.
Office of the Provincial Auditor of Saskatchewan · Provincial Auditor
Operational audit of SHA's Opioid Agonist Treatment (OAT) and Rapid Access Addiction Medicine (RAAM) clinics — funding mechanisms and delivery efficacy.
Of $306M SHA mental-health/addictions budget (2024–25), only $4.6M was allocated specifically to OAT/RAAM infrastructure. Indigenous people made up 55% of confirmed opioid-toxicity deaths in 2024.
Provincial Court of Saskatchewan
Official judicial notice clarifying that the Provincial Court is not currently accepting applications or processing warrants under the Compassionate Intervention Act.
Pilot involuntary-treatment program expected to commence Fall 2026, centralized at Saskatchewan Hospital, North Battleford.
Government of Saskatchewan
Public-facing policy document explaining legal mechanisms, assessment protocols, and safeguards in the province's involuntary addiction-treatment model.
Canadian Centre on Substance Use and Addiction (CCSA)
National evidence brief on the clinical, ethical, and systemic complexities of involuntary treatment for severe substance use disorders in Canada.
Synthesis finds InvTx does not produce long-term reductions in substance use or reoffending and is linked to increased post-discharge overdose risk and re-traumatization.
Office of the Provincial Health Officer, British Columbia
Public-health review of clinical rationale, population-level benefits, and diversion risks of Prescribed Safer Supply (PSS) in BC.
No corresponding increase in OUD diagnoses among youth or any other cohort since the 2020 Risk Mitigation Guidelines; some diversion acknowledged.
EMCDDA & Correlation European Harm Reduction Network
Programmatic evaluation of more than 100 Drug Consumption Rooms across European jurisdictions — operational mechanics, clinical outcomes, and public-order impacts.
DCRs eliminate on-site fatal overdoses, sharply reduce HIV/HCV transmission and public nuisance, with no measurable increase in local crime.
Canadian Institutes of Health Research / Centre on Drug Policy Evaluation · Werb D
CIHR-funded evaluation of 25 federally funded integrated safer-supply pilot programs across Canada.
Safer-supply pilots reduced opioid toxicity events, reliance on street drugs, and hospitalizations; key gap is lack of formulations potent enough to match street-fentanyl tolerance.
Ballotpedia
Statutory breakdown of Measure 110, which reclassified Schedule I–IV drug possession to a Class E violation and redirected cannabis tax revenue to recovery services.
Transform Drug Policy Foundation (UNODC document repository)
Long-term, multi-decade epidemiological synthesis of Portugal's 2001 decriminalisation, drawing on EMCDDA data.
Problematic drug use, injecting drug use, and HIV infection rates dropped sharply; use among 15–24-year-olds declined post-reform.
Curated and maintained by Voluntary Treatment First Saskatchewan. Every entry links to a peer-reviewed journal, government report, university, or major public-health agency. Spot a broken link or missing study? Let us know.
